Fosun Pharma Industrial

BRIEF: Fosun Pharma raises stake in Henlius

Fosun Pharma (2196.HK) announced on Monday that its wholly owned unit, Fosun Pharma Industrial, acquired 21.03 million unlisted shares of its Henlius (2696.HK) subsidiary for HK$517 million ($66.6 million), or…
2196.HK 2696.HK

Recent Articles

RELATED ARTICLES

  1. Henlius Bio
    After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK
  2. Fosun moves on from debt crisis with renewed focus on tourism, healthcare
    0656.HK
  3. Fosun Tourism travels back to home base with delisting plan
    1992.HK 0656.HK
  4. BRIEF: Fosun pledges 27% of Fosun Pharma’s A-shares
    2196.HK 600196.SHG
  5. Earnings blow for CSPC Pharma as the state drives a hard bargain
    1093.HK
  6. Innovent ditches low-value stake sale after investor outcry
    1801.HK
  7. Battered Lanvin hopes for better 2025 as executive revolving door keeps turning
    LANV.US
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva